ישראל -
עברית -
Ministry of Health
לוטויסיל וטרינרי
m.p.vet ltd - d - cloprostenol as sodium - תמיסה להזרקה - d - cloprostenol as sodium 75 mcg / 1 ml - the product is indicated for cows, sows and mares for : - oestrus indication and synchronization in cows. - parturition induction in cows, sows and mares. oestrus induction in mares. - ovarian dysfunction with corpus luteum present : post-parturition anoestrus, silent heat, irregular cycle and sycle without ovulation, persistent corpus lutem, luteinic cysts. - endometritis, pyometra. - interruption of gestation (during the first half), foetal mummification. - post - puerperal metropathy, delayed uterine involution. - combined follicular cyst therapy ( 10 - 14 days after administration gnrh or hcg ).
ישראל -
עברית -
Ministry of Health
קלקסן
sanofi israel ltd - enoxaparin sodium - תמיסה להזרקה - enoxaparin sodium 100 mg/ml ml - enoxaparin - enoxaparin - enoxaparin sodium is an anti-coagulant. at dosesof 20 mg and 40 mg it is indicated for: - prophylactic treatment of thrombo-embolic disorders of venous origin and in particular in orthopedic surgery or in general surgery. - prevention of thrombus formation in the extra-corporeal circulation during hemodialysis. at dosege of 40 mg the indications are: - prophylactic treatment of deep vein thrombosis in patients who are bedridden due to an acute medial disorder: - heart failure (hyha class iii or iv) - acute respiratory failure - episode of acute infection or acute rheumatic disorder combined with at least one other venous thromboembolic risk factor. at high doses of 60, 80 ,100 mg clexan is indicated for: -treatment of deep vein thrombosis (dvt). - treatment of unstable angina and non-q-wave myocardial infaction administered concurrently with aspirin. - treatment of pulmonary embolism.treatment of acute st- segment elevation myocardial infarction, in combination with a thrombolytic agent in patients eligible o
ישראל -
עברית -
Ministry of Health
לוטמקס תרחיף
abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po
ישראל -
עברית -
Ministry of Health
זיילט
abic marketing ltd, israel - loteprednol etabonate; tobramycin - תרחיף לעין - tobramycin 3 mg/ml; loteprednol etabonate 5 mg/ml - tobramycin - tobramycin - zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.the particular anti-infect
ישראל -
עברית -
Ministry of Health
prismocitrate 10/2
טבע מדיקל (שיווק) בע"מ - אחות - regional citrate anticoagulation in extracorporeal circuit during continuous renal replacement therapies
ישראל -
עברית -
Ministry of Health
cypher sirolimus eluting stent
j-c healthcare ltd. - רופא - תומכון להרחבה והיצרות חוזרת בעורק
ישראל -
עברית -
Ministry of Health
קורפורל - מרכך הרודס - פתאל
א.ל. ארמן יצור תמרוקים בעמ - ריכוך השיער